glp-1 drugs pill form With FDA approval of Wegovy pill, new era of oral weight loss begins Weight-Loss Pill Study Compares Effectiveness
Description
As shown in Scheme 1

At least in the US, the numbers are truly staggering with c 44% of people belonging in the obese or overweight group, which could increase to 53% by the end of the decade
PMID: 23728174 (This study is OPEN ACCESS if you would like to read it) The researchers gave exenatide (the Byetta formulation which is injected twice per day) to a group of 21 people with moderate Parkinsons and evaluated their progress over a 14 month period
Fundamental processes affected by GLP-1s In some cases, the problems GLP-1s can solve stem directly from their weight reduction effect

They found it easier to resist cravings and cut back on addictive behaviors, particularly around food

For A 1-42 -induced AD model, exendin-4 mitigated abnormal behavior and prevented A1-42-induced impairment of LTP (85, 189, 226)
